nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing cultural and political drivers of vaccine hesitancy: Considerations for the African and Asian contexts
|
Kohli, Khushi |
|
|
42 |
7 |
p. 1411-1413 |
artikel |
2 |
A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies
|
Faber, Bart W. |
|
|
42 |
7 |
p. 1785-1792 |
artikel |
3 |
AI and the future of vaccine development
|
Koff, Wayne C. |
|
|
42 |
7 |
p. 1407-1408 |
artikel |
4 |
A population-based, province-wide, record-linkage interrupted time series analysis of impact of the universal seasonal influenza vaccination policy on seasonal influenza vaccine uptake among 5–64-year-olds in the province of Manitoba, Canada
|
Okoli, George N. |
|
|
42 |
7 |
p. 1571-1581 |
artikel |
5 |
Attitudes and behaviors of maternal Tdap vaccination in Panama, Peru, and Colombia: An international cross-sectional study
|
McDermid, Pippa |
|
|
42 |
7 |
p. 1698-1703 |
artikel |
6 |
Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data
|
Kochhar, Sonali |
|
|
42 |
7 |
p. 1812-1825 |
artikel |
7 |
CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description
|
Madni, Sabrina A. |
|
|
42 |
7 |
p. 1469-1477 |
artikel |
8 |
Celebrating vaccines: The 2023 Nobel prize in medicine or physiology
|
Poland, Gregory A. |
|
|
42 |
7 |
p. 1409-1410 |
artikel |
9 |
Computational design of mRNA vaccines
|
Kim, Yoo-Ah |
|
|
42 |
7 |
p. 1831-1840 |
artikel |
10 |
Cost-benefit of influenza vaccination in preventing sudden cardiac arrest amongst Australian adults
|
Wei, Jenny |
|
|
42 |
7 |
p. 1593-1598 |
artikel |
11 |
COVID-19 vaccine perspectives and uptake among university students three years into the pandemic
|
Kuter, Barbara J. |
|
|
42 |
7 |
p. 1745-1756 |
artikel |
12 |
Did the COVID-19 experience change U.S. parents’ attitudes towards HPV vaccination? Results from a national survey
|
Klassen, Ann C. |
|
|
42 |
7 |
p. 1704-1713 |
artikel |
13 |
Early detection of emerging infectious diseases - implications for vaccine development
|
Raina MacIntyre, C. |
|
|
42 |
7 |
p. 1826-1830 |
artikel |
14 |
Editorial Board
|
|
|
|
42 |
7 |
p. ii |
artikel |
15 |
Effectiveness of the combined MMRV Priorix-Tetra™ vaccine against varicella in a large Italian region: A case-control study
|
Fortunato, Francesca |
|
|
42 |
7 |
p. 1608-1616 |
artikel |
16 |
Erratum to “BCGΔBCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice” [Vaccine 41(26) (2023) 3824–3835]
|
Aceves-Sánchez, Michel de Jesús |
|
|
42 |
7 |
p. 1852-1853 |
artikel |
17 |
Expression of Concern: “Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine” [Vaccine [33/1], 1 January 2015, Pages 108–116]
|
|
|
|
42 |
7 |
p. 1851 |
artikel |
18 |
Expression of Concern: “Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses” [Vaccine Volume 38, Issue 4, 22 January 2020, Pages 830–839]
|
|
|
|
42 |
7 |
p. 1850 |
artikel |
19 |
Food insecurity and COVID-19 vaccine hesitancy among adults in the United States (US)
|
Hearn, Elizabeth B. |
|
|
42 |
7 |
p. 1723-1730 |
artikel |
20 |
Genomic and transcriptomic analysis of the recent Mpox outbreak
|
Giorgi, Federico M. |
|
|
42 |
7 |
p. 1841-1849 |
artikel |
21 |
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations
|
Lavell, A.H.A. |
|
|
42 |
7 |
p. 1478-1486 |
artikel |
22 |
Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice
|
Manning, Jayne |
|
|
42 |
7 |
p. 1714-1722 |
artikel |
23 |
Immunogenicity and safety in rabbits of a Clostridioides difficile vaccine combining novel toxoids and a novel adjuvant
|
Aminzadeh, Aria |
|
|
42 |
7 |
p. 1582-1592 |
artikel |
24 |
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial
|
Jin, Fei |
|
|
42 |
7 |
p. 1561-1570 |
artikel |
25 |
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study
|
Shoukat, Affan |
|
|
42 |
7 |
p. 1768-1776 |
artikel |
26 |
Implications of information heard about Dengvaxia on Filipinos' perception on vaccination
|
Mabale, Maria Angela A. |
|
|
42 |
7 |
p. 1673-1681 |
artikel |
27 |
Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients
|
Whitaker, Heather J. |
|
|
42 |
7 |
p. 1656-1664 |
artikel |
28 |
Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine
|
Wadapurkar, Rucha |
|
|
42 |
7 |
p. 1630-1647 |
artikel |
29 |
Literature review to identify evidence of secondary transmission of pentavalent human-bovine reassortant rotavirus vaccine (RV5) strains to unvaccinated subjects
|
Li, Yuanqiu |
|
|
42 |
7 |
p. 1461-1468 |
artikel |
30 |
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study
|
Rivers, Patrick |
|
|
42 |
7 |
p. 1512-1520 |
artikel |
31 |
Mechanism study of cross presentation of exogenous antigen induced by cholera toxin-like chimeric protein
|
He, Xianying |
|
|
42 |
7 |
p. 1549-1560 |
artikel |
32 |
Mortality risk after COVID-19 vaccination: A self-controlled case series study
|
Xu, Stanley |
|
|
42 |
7 |
p. 1731-1737 |
artikel |
33 |
2022 Polio outbreak, Rockland County, NY: Cost evaluation of strategies to prevent future outbreaks of vaccine-preventable diseases
|
Pike, Jamison |
|
|
42 |
7 |
p. 1793-1798 |
artikel |
34 |
Probability of exposure to the wild measles virus in adult population – Estimation from seroepidemiology and historical data
|
Zibolenová, Jana |
|
|
42 |
7 |
p. 1648-1655 |
artikel |
35 |
Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules
|
Valentin, Julie |
|
|
42 |
7 |
p. 1487-1497 |
artikel |
36 |
Report from the World Health Organization’s immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11–13 September 2023
|
Lambach, Philipp |
|
|
42 |
7 |
p. 1424-1434 |
artikel |
37 |
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains
|
Bharucha, Tehmina |
|
|
42 |
7 |
p. 1506-1511 |
artikel |
38 |
Resurgent rotavirus diarrhoea outbreak five years after introduction of rotavirus vaccine in Botswana, 2018
|
Weldegebriel, Goitom G. |
|
|
42 |
7 |
p. 1534-1541 |
artikel |
39 |
Rhode Island as a model for promoting flu vaccination in the United States
|
Batheja, Aashish |
|
|
42 |
7 |
p. 1417-1419 |
artikel |
40 |
Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study
|
Kim, Hee Kyoung |
|
|
42 |
7 |
p. 1440-1444 |
artikel |
41 |
Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy
|
Buekens, Pierre |
|
|
42 |
7 |
p. 1414-1416 |
artikel |
42 |
Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine
|
Toback, Seth |
|
|
42 |
7 |
p. 1777-1784 |
artikel |
43 |
SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost
|
Lijeskić, Olivera |
|
|
42 |
7 |
p. 1665-1672 |
artikel |
44 |
Shiga toxin type 2 B subunit protects mice against toxin challenge when leashed and bundled by a stable pentameric coiled-coil molecule
|
Tamaki, Yukihiro |
|
|
42 |
7 |
p. 1757-1767 |
artikel |
45 |
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK
|
Hyams, Catherine |
|
|
42 |
7 |
p. 1599-1607 |
artikel |
46 |
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study
|
Maeda, Megumi |
|
|
42 |
7 |
p. 1542-1548 |
artikel |
47 |
The collaboration on social science and immunisation (COSSI): Global lessons from a successful Australian research and practice network
|
Attwell, Katie |
|
|
42 |
7 |
p. 1420-1423 |
artikel |
48 |
The coverage of influenza vaccination and predictors of influenza non-vaccination in Danish cancer patients: A nationwide register-based cohort study
|
Amdisen, Lau |
|
|
42 |
7 |
p. 1690-1697 |
artikel |
49 |
The potential impact of PCV-13, PCV-15 and PCV-20 vaccines in Colombia
|
Serrano-Mayorga, Cristian C. |
|
|
42 |
7 |
p. 1435-1439 |
artikel |
50 |
The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data
|
Grima, Alicia A. |
|
|
42 |
7 |
p. 1498-1505 |
artikel |
51 |
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations
|
Banerjee, Soumalya |
|
|
42 |
7 |
p. 1454-1460 |
artikel |
52 |
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops
|
Baqar, Shahida |
|
|
42 |
7 |
p. 1445-1453 |
artikel |
53 |
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
|
Schönborn, Linda |
|
|
42 |
7 |
p. 1799-1811 |
artikel |
54 |
Use of invitations and reminders are associated with higher levels of Herpes zoster (shingles) vaccination uptake. A cross-sectional survey of general practices in Wales, and ecological analysis of uptake data, 2022
|
Rowley, Frances |
|
|
42 |
7 |
p. 1682-1689 |
artikel |
55 |
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021
|
Nguyen, Kimberly H. |
|
|
42 |
7 |
p. 1617-1629 |
artikel |
56 |
Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021
|
Mziou, Emna |
|
|
42 |
7 |
p. 1738-1744 |
artikel |
57 |
Value of information dynamics in Disease X vaccine clinical trials
|
Houy, Nicolas |
|
|
42 |
7 |
p. 1521-1533 |
artikel |